SERNOVA BIOTHERAPEUTICS INC (PSH0.DE) Stock Income Statement
FRA:PSH0 - Deutsche Boerse Ag - CA81752F1062 - Common Stock - Currency: EUR
| TTM (2025-1-31) | 2024 (2024-10-31) | 2023 (2023-10-31) | 2022 (2022-10-31) | 2021 (2021-10-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 26.44M | 31.66M | 40.50M | 24.75M | 6.94M | |||
| Research and Development | 17.59M | 22.18M | 31.63M | 16.49M | 4.38M | |||
| Selling, General, and Administrative Expenses | 8.37M | 8.94M | 8.43M | 7.83M | 2.29M | |||
| Operating Income | -26.44M | -31.66M | -40.50M | -24.75M | -6.94M | |||
| Interest Income/Expense | -1.69M | -540.30K | 1.50M | 333.20K | 19.20K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | -48.20K | |||
| Income Before Taxes | -28.13M | -32.19M | -39.00M | -24.42M | -6.97M | |||
| Income Tax | N/A | 7.00K | N/A | N/A | N/A | |||
| Net Income | -28.14M | -32.19M | -39.00M | -24.42M | -6.97M | |||
| EBITDA | -25.95M | -31.12M | -40.06M | -24.31M | -6.67M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.09 | -0.10 | -0.13 | -0.09 | -0.03 | |||
| Non GAAP EPS | N/A | -0.09 | -0.13 | -0.09 | N/A | |||
| Statistics | ||||||||
All data in CAD